Results 261 to 270 of about 96,820 (286)
Some of the next articles are maybe not open access.
Pharmacodynamic modeling of finasteride, a 5 alpha-reductase inhibitor.
Pharmacotherapy, 1995Finasteride is a 4-azasteroid inhibitor of one isoenzyme of 5 alpha-reductases that converts testosterone to dihydrotestosterone (DHT). We characterized the time course of DHT concentrations. The following model was used to assess DHT pharmacodynamics: [formula: see text] where joint fitting of three dose levels yielded kin0 = 28% change/hour, kout = 0.
H C, Ko, W J, Jusko
openaire +1 more source
Treatment of hirsutism with 5 alpha-reductase inhibitors.
Clinics in endocrinology and metabolism, 1986Much os the evidence gathered from studies of 5 alpha-reductase activity levels and androgen metabolism in the skin of hirsute women and the excretion of androgen metabolites by hirsute women indicates that 5 alpha-reduced androgens are probably of primary importance in hirsutism.
openaire +1 more source
5-alpha reductase inhibitors and PSA screening for prostate cancer
Pathology, 2014Paul R, McKenzie +3 more
openaire +4 more sources
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
Lancet, The, 2000K Arnold Chan, Richard Platt
exaly
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Ca-A Cancer Journal for Clinicians, 2011Timothy A Yap, Johann Sebastian de Bono
exaly
The risk of dementia with the use of 5 alpha reductase inhibitors
Journal of the Neurological Sciences, 2017Blayne Welk +2 more
exaly

